home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Eureka Genomics launches a novel custom genotyping service


Hercules, California, USA
April 30, 2013

Eureka Genomics (EG) has launched a custom service for the detection of a moderate number of markers in a large sample number of samples; a low cost, low density marker assay (LDMA). This platform addresses the gap between traditional array technologies and multiplex PCR and is designed for the customized detection of hundreds of SNPs in thousands of samples using a single lane of an Illumina next generation sequencer. Instead of making large amounts of data on small numbers of sample, LDMA makes very focused data on a large number of samples.

According to EG, this service can be used very broadly and provides researchers with an affordable tool to validate the putative makers from GWA and other types of studies. This custom service utilizes the power of next generation sequencing data generation and EG’s proprietary bioinformatics and can be applied to the detection of SNPs, CNV, presence/absence and methylation. It can be used with DNA or RNA, with model organisms, commercial organisms or exotic organisms, and with complete or incomplete genomes.

“With this new service, individual researchers can harness the cost effectiveness of next generation sequencers to produce massive amounts of data that is focused on their biological sequences and SNPs of interest over large numbers of samples,” said Heather Koshinsky, CSO, Eureka Genomics. “Instead of spending resources on all the extra data that accompany traditional arrays and sequencing, with the LDMA service researchers can focus on their biomarkers of interest and move more quickly and cost effectively to understand their biological question or disease.”

Eureka Genomics is a leader in advanced bioinformatics analysis of next-generation sequencing data, which it applies to the discovery of microorganisms associated with cancers and other life threatening diseases, the development of molecular diagnostics, and low density marker assays. EG leverages its proprietary algorithms and biological problem-solving expertise and provides collaborative, cost-effective high quality sequencing and analysis services to a broad range of university, government and industry researchers worldwide.



More news from: Eureka Genomics


Website: http://www.eurekagenomics.com

Published: April 30, 2012

The news item on this page is copyright by the organization where it originated
Fair use notice

 
 
 
 
 
 
 
 
 
 
 

  Archive of the news section

 

 


Copyright @ 1992-2026 SeedQuest - All rights reserved